Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TMEM11 divergent transcript (TMEM11-DT) is annotated as a non-coding RNA gene located on human chromosome 17. It is listed in gene databases (NCBI Gene ID: 107984969, Ensembl ID: ENSG00000235530). Unlike the protein-coding gene TMEM11, which encodes a mitochondrial membrane protein involved in regulating mitochondrial morphology, TMEM11-DT does not encode a protein and its biological function, clinical significance, or role in disease and drug targeting is currently unknown. There are no well-established aliases, biological functions, disease associations, or known drug interactions for TMEM11-DT. It is not considered a therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TMEM11 divergent transcript (TMEM11-DT).